FINWIRES · TerminalLIVE
FINWIRES

Research Alert: CFRA Maintains Buy Opinion On Shares Of Grab Holdings Limited

By

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

We maintain our USD4.50 target price for Grab, valuing the stock at 26.5x 2026 EV/EBITDA, above its peer average forward EV/EBITDA of 10.6x. We keep our 2026/2027 EPS estimates unchanged. Our Buy rating is supported by strong momentum continuing into Q1 2026. The strategic acquisition of foodpanda Taiwan marks Grab's first expansion outside Southeast Asia, adding a profitable USD1.8 billion GMV market expected to be accretive to 2026 revenue. This move positions Grab well toward its ambitious 2028 target of USD1.5 billion in Adjusted EBITDA. The USD400 million share buyback program further reinforces management's confidence in value creation. Despite near-term headwinds from elevated crude oil prices that may pressure driver margins and consumer demand, we believe Grab's diversification across delivery and financial services, combined with its market-leading position in the high-growth Southeast Asia region, provides meaningful resilience to sustain its long-term profitable growth trajectory.

Related Articles

Research

Research Alert: CFRA Reiterates Buy Opinion On Shares Of News Corp

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $2 to $31, 26x our FY 27 (Jun.) EPS estimate (unchanged multiple). We raise our FY 26 EPS estimate to $1.03 from $0.99 and FY 27's to $1.19 from $1.13. Following FQ3 (Mar-Q) results, we are reiterating our Buy opinion. We are encouraged by results at Dow Jones, where revenue growth is accelerating in its Risk & Compliance (+19% Y/Y) and Energy (+12% Y/Y) products. The Dow Jones segment also saw Wall Street Journal subscriptions reach 4.7M (+8% Y/Y) despite higher subscription prices, demonstrating pricing power. The company's Digital Real Estate Services grew revenue (+8% Y/Y ex-FX) despite new and existing home sales remaining in a slump. Adjusted EBITDA margins have expanded for eight consecutive quarters post-Foxtel spin-off, fueling improved free cash flow and accelerated buybacks. At 26x our FY 27 estimate vs. a 29x five-year average, shares trade at a discount with potential for re-rating as operational momentum continues.

$NWSA
Research

Research Alert: CFRA Keeps Hold Rating On Shares Of Genpact Limited

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target price by $9 to $36, 8.3x our 2027 EPS estimate vs. G's three-year historical forward P/E average of 12.1x and the peer average of 11.6x. We raise our 2026 EPS view to $4.04 from $3.99 and keep 2027's unchanged at $4.34. We think G faces operational risks, including execution hurdles in scaling its new AI-driven offerings against intense competition. However, these concerns are partly overshadowed by the exceptional momentum in its strategic pivot, highlighted by a 24% surge in ATS revenue. In a major proof point of this shift, the company secured nearly double the contract value for its new Agentic solutions in Q1 alone compared to all of 2025, demonstrating rapid market adoption. This successful transition towards higher-margin, IP-based recurring revenue is structurally improving profitability, evidenced by 12 consecutive quarters of gross margin expansion. Sustaining this high-stakes execution and improving cash conversion remain critical to fully de-risking the company's transformation.

$G
Research

Research Alert: CFRA Maintains Strong Buy Rating On Shares Of Epam Systems, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We cut our target from $231 to $184, 14x our 2026 EPS view, below EPAM's three-year average (19x) on AI competition risk. We raise our 2026 EPS view by $0.31 to $13.13 and 2027's by $0.23 to $14.53. Profitability continues to improve, supported by operational discipline and improved pricing in certain cases, which helps provide support to our view that EPAM is favorably positioned for more AI-focused projects. To this point, EPAM's AI revenues continue to grow solidly, up 19% Q/Q to $125M in Q1 for the fifth-straight double-digit sequential increase. Despite more bearish fears that the company's revenue deceleration (with its 2026 organic CC guide coming down to ~5.25% from ~6% prior), we see clear negative impacts from macro factors (i.e., the war in Iran) that should prove temporary, allowing for multiple expansion once these factors fade and AI deal momentum becomes more clear. Still, our lower target reflects heightened risks of perceived AI competition as impressive new AI models continue to roll out.

$EPAM